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Pseudomonas aeruginosa is an opportunistic pathogen that con-
trols numerous virulence factors through intercellular signals. This
bacterium has two quorum-sensing systems (las and rhl), which act
through the intercellular signals N-(3-oxododecanoyl)-L-homo-
serine lactone (3-oxo-C12-HSL) and N-butyryl-L-homoserine lactone
(C4-HSL), respectively. P. aeruginosa also produces a third intercel-
lular signal that is involved in virulence factor regulation. This
signal, 2-heptyl-3-hydroxy-4-quinolone [referred to as the Pseudo-
monas quinolone signal (PQS)], is a secondary metabolite that is
part of the P. aeruginosa quorum-sensing hierarchy. PQS can
induce both lasB (encodes LasB elastase) and rhlI (encodes the
C4-HSL synthase) in P. aeruginosa and is produced maximally
during the late stationary phase of growth. Because PQS is an
intercellular signal that is part of the quorum-sensing hierarchy
and controls multiple virulence factors, we began basic studies
designed to elucidate its biosynthetic pathway. First, we present
data that strongly suggest that anthranilate is a precursor for PQS.
P. aeruginosa converted radiolabeled anthranilate into radioactive
PQS, which was bioactive. We also found that an anthranilate
analog (methyl anthranilate) would inhibit the production of PQS.
This analog was then shown to have a major negative effect on
elastase production by P. aeruginosa. These data provide evidence
that precursors of intercellular signals may provide viable targets
for the development of therapeutic treatments that will reduce P.
aeruginosa virulence.
P seudomonas aeruginosa is an opportunistic Gram-negativebacterium that causes serious infections in plants, animals,
and humans. This pathogen is a common cause of nosocomial
infections and is responsible for chronic lung infections in over
90% of cystic fibrosis patients (1, 2). The effectiveness of this
organism as an opportunistic pathogen is due to an arsenal of
well-regulated virulence factors. One method by which P. aerugi-
nosa controls a large number of genes, many of which are
important for virulence, is through the mechanism known as
quorum sensing (for reviews see refs. 3 and 4). Quorum sensing
systems use a cell-to-cell signal to sense cell density and subse-
quently activate a transcriptional regulator that induces specific
genes. In P. aeruginosa, two signals function to activate the las
and rhl quorum-sensing systems and thereby regulate an esti-
mated 3–5% of the genes in the genome (5). The las and rhl
signals are N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-
C12-HSL) and N-butyryl-L-homoserine lactone (C4-HSL), re-
spectively (6, 7). In addition to these acylated homoserine
lactone signals, P. aeruginosa also produces a secondary metab-
olite that functions as an intercellular signal. This unique signal
was identified as 2-heptyl-3-hydroxy-4-quinolone and is referred
to as the Pseudomonas quinolone signal (PQS) (8). PQS can
activate the genes for both LasB elastase (lasB) and the C4-HSL
synthase (rhlI) in P. aeruginosa (8, 9). This signal was also shown
to be part of the quorum-sensing hierarchy in P. aeruginosa,
inasmuch as its production and activity depended on LasR and
RhlR, respectively (8). However, the production of this signal
during the growth cycle occurs much later than the activation of
the quorum-sensing cascade of which it is a part (9). This finding
led to the conclusion that PQS may be involved in signaling at
a time of increased cell stress.
It could be conservatively estimated that P. aeruginosa pro-
duces more than 50 secondary metabolites, many of which were
discovered because they possess antibiotic activity (10). Antibi-
otic activity has not been demonstrated by PQS (8), even though
it is very similar to a class of P. aeruginosa-produced antibiotics
referred to as ‘‘pyo compounds’’ (4-hydroxyquinolines). The
4-quinolone base structure of PQS also suggests that it can be
synthesized through a mechanism similar to that for pyo com-
pounds. Previous studies on pyo compound synthesis provided
evidence that they were produced through the condensation of
anthranilate and a b-keto-fatty acid (11).
In this study, we set out to learn more about the synthesis of
PQS. We began by determining that anthranilate is a precursor
for PQS. We also show that an anthranilate analog caused a
decrease in PQS production and elastase activity in P. aerugi-
nosa. The data presented allow us to suggest that a fundamental
metabolite such as anthranilate may be targeted to interrupt
cell-to-cell signaling and thereby prevent virulence factor
production.
Materials and Methods
Bacterial Strains, Plasmids, and Media. The following P. aeruginosa
strains were used in this study: PAO1 (wild type) (12), PAO-R1
(lasR) (13), PAO-JP2 (lasI, rhlI) (14), and PAO-JP3 (lasR, rhlR)
(14). Plasmid pECP39 (8) encodes a truncated form of LasR that
is capable of activating LasR-controlled genes in the absence of
autoinducer. All strains were maintained in 10% (wtyvol) skim
milk (Becton Dickinson) at 270°C. Freshly plated cells from
skim milk stocks were used to begin all experiments. Unless
indicated otherwise, P. aeruginosa strains were grown in peptone
trypticase soy broth (15) supplemented with 200 mgyml carben-
icillin when necessary to maintain a plasmid. Liquid cultures
were grown at 37°C and shaken at 250 rpm.
Experiments with Radioactive Anthranilate. Freshly plated cells of
P. aeruginosa strains PAO1, PAO-R1, PAO-JP2, and PAO-JP2
(pECP39) were used to inoculate 10-ml cultures for overnight
growth. Overnight cultures were washed and used to inoculate
a 10-ml subculture to an OD660 of 0.05. Subcultures were
incubated until they reached the mid-logarithmic phase of
growth and then were washed and added to flasks (starting
OD660 5 0.05) containing 2 mCi of 12.5 mCiymmol [ring-U-
14C]anthranilic acid (Sigma-Aldrich). Cultures were then grown
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for 19 h in the presence of radiolabeled anthranilic acid. Total
radioactivity of the cultures was calculated by measuring an
aliquot of each culture at the end of the growth period. [Note:
To measure radioactivity, triplicates of all samples were assayed
for 2 min in 3 ml of Becton Dickinson ScintiVerse scintillation
fluid with a Beckman LS5000TD scintillation counter, and
results are presented as the mean 6 one standard deviation
(sn21).] Cells were then harvested by centrifugation at 10,000 3
g for 10 min at room temperature in a Sorvall SA-600 rotor. Cell
pellets were resuspended in deionized H2O, and aliquots were
assayed to determine the amount of radioactivity associated with
the P. aeruginosa cells. Culture supernatants were then extracted
twice with the use of 1 vol of HPLC-grade ethyl acetate. (Note:
All ethyl acetate used in these studies was supplemented with
glacial acetic acid to a final concentration of 435 mM.) After
centrifugation as before, the organic and aqueous phases of the
extract were placed in separate flasks and water was removed
from the ethyl acetate phase with sodium sulfate. Aliquots from
the aqueous and ethyl acetate fractions of the extract were
assayed to determine the amount of radioactivity contained by
each fraction. Ethyl acetate extracts were then dried by rotary
evaporation and stored at 220°C until further analysis.
PQS Analysis and Purification by TLC. All TLC plates (20 3 20 cm
silica gel 60 F254) (EM Science) were soaked in 5% KH2PO4 and
activated at 100°C for 1 h as described (8). Culture supernatant
extracts were separated with the use of 17:2:1 methylene chlo-
rideyacetonitrileydioxane as the solvent. This process was de-
termined to be optimal for purification of PQS (8). Plates were
then air dried and visualized under UV light andyor exposed to
Kodak X-Omat x-ray film.
Purification of PQS from TLC plates was performed as
described (8). Upon the completion of ethyl acetate extractions,
samples were reconstituted in a small volume of a 1:1 mixture of
acetonitrile and ethyl acetate and loaded onto TLC plates. After
development, PQS was visualized with long-wave UV light and
scraped from the plate. PQS was eluted from the silica gel with
two 3-ml washes of 1:1 acetonitrileyethyl acetate, and silica gel
was removed by centrifugation at 10,000 3 g for 10 min. The
resulting sample was dried by rotary evaporation and reconsti-
tuted in 50 ml of 1:1 acetonitrileyethyl acetate. This sample was
applied again to a TLC plate and separated by two-dimensional
TLC with the same solvent conditions as above. PQS was
visualized and purified as described before. This technique has
been shown to provide pure PQS (8).
For experiments that included methyl anthranilate (ICN), P.
aeruginosa strain PAO1 was grown in the presence of increasing
concentrations of methyl anthranilate. Culture supernatants
were extracted with ethyl acetate, and extracts were loaded onto
TLC plates. Plates were photographed under long-wave UV
light, and photographs were analyzed with the use of the
IMAGEQUANT program (Molecular Dynamics) to determine rel-
ative amounts of PQS.
Elastase Assay. Elastase activity produced by P. aeruginosa strains
grown in the absence or presence of methyl anthranilate was
measured by a modified elastin Congo red (ECR) assay (16).
Freshly plated cells of P. aeruginosa strains PAO-JP3 and PAO1
were used to inoculate 10-ml cultures for overnight growth.
Overnight cultures were washed and used to inoculate a subcul-
ture to an OD660 of 0.05. Subcultures were grown to the
mid-logarithmic phase, subcultured again to an OD660 of 0.05,
and added to flasks containing increasing concentrations of
methyl anthranilate. Cultures were then grown for 20 h at 37°C
with shaking. Culture supernatants were recovered by centrifu-
gation at 10,000 3 g for 10 min at room temperature in a Sorvall
SA-600 rotor. Supernatants were then passed through a 0.45-mm
HT Tuffryn syringe filter (Gelman Sciences). One milliliter of
filtrate was added to 1 ml of ECR buffer (0.1 M TriszHCly1 mM
CaCl2, pH 7.2) containing 20 mg of ECR (Sigma-Aldrich). Tubes
were incubated for 3 h at 37°C with shaking at 250 rpm.
Elastolytic activity results in the cleavage of ECR, which releases
a soluble red pigment. After incubation, 0.2 ml of 0.12 M
Na2EDTA was added to stop the reaction. Insoluble ECR was
separated by centrifugation at 3,500 3 g for 10 min, and the
absorbance of the supernatant at 495 nm was measured. The A495
of samples incubated in the absence of culture filtrate was
considered background activity, and this value was subtracted
from all samples.
Results
Anthranilate Is a Precursor of PQS. P. aeruginosa produces numer-
ous secondary metabolites, including several 2-alkyl-4-
hydroxyquinolines, which are referred to as ‘‘pyo compounds’’
(10). In previous work, it was proposed that 4-quinolones (such
as PQS) are pyo compound precursors that result from the
condensation of anthranilate and a b-keto-fatty acid (11). These
results and the 4-quinolone base structure of PQS led us to
believe that anthranilate is a PQS precursor. To begin to test this
hypothesis, P. aeruginosa strains that produce PQS [PAO1 and
PAO-JP2(pECP39)] (8) and non-PQS-producing strains (PAO-
JP2 and PAO-R1) (8) were grown in the presence of 14C-ring-
labeled anthranilate. The cells were harvested and culture
supernatants were extracted with ethyl acetate. Radioactivity in
the extracts, cell pellets, and culture supernatants from these
cultures was counted to determine the percentage of radioac-
tivity contained by each fraction. The percentages of radioac-
tivity contained in the cell pellets from strains PAO1, PAO-JP2,
and PAO-JP2 (pECP39) were similar (between 15% and 20%),
and the cell pellet from strain PAO-R1 contained ’33% of the
total radioactivity added (Fig. 1). More interestingly, the ma-
jority of the total radioactivity added to the PQS-producing
strains, PAO1 (56%) and PAO-JP2(pECP39) (54%), was found
Fig. 1. Fate of [14C]anthranilate in P. aeruginosa. Strains PAO1 (solid bars),
PAO-R1 (striped bars), PAO-JP2(pECP39) (stippled bars), and PAO-JP2 (unfilled
bars) were grown in the presence of [14C]anthranilate. Cultures were centri-
fuged, and culture supernatant was extracted with acidified ethyl acetate. The
percentage of total radioactivity contained by cell pellets and the aqueous
and organic phases of culture supernatant extracts was determined. Data are
the mean 1 sn21 of triplicate counts from three separate experiments and are
presented as the percentage of total radioactivity added to the cultures. As a
control to ensure complete recovery of radioactivity, the empty culture flasks
were washed with ethanol, which was then assayed for radioactivity.
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in the ethyl acetate extract fraction (Fig. 1). This finding was
quite different from the percentage of total radioactivity found
in the extracts from the quorum-sensing mutants, strains
PAO-R1 and PAO-JP2. Culture supernatant extracts from
strains PAO-R1 and PAO-JP2 contained an average of 3% and
4%, respectively, of the total radioactivity added (Fig. 1). The
majority of radioactivity in these strains was found in the
aqueous phase of the culture supernatant extraction, which
contained 68% and 51% of the total radioactivity added to
strains PAO-R1 and PAO-JP2, respectively (Fig. 1). These data
indicate that quorum-sensing mutants (which do not produce
PQS) do not convert anthranilate into compounds that can be
extracted with ethyl acetate. This finding was a surprise because
it has been proposed that numerous secondary metabolites
produced by P. aeruginosa are derived from anthranilate (11).
This hypothesis leads us to speculate that quorum sensing may
be necessary for an early step in the utilization of anthranilate
as a precursor for some secondary metabolites.
To determine whether the radiolabeled anthranilate was
actually being converted to PQS, we examined the ethyl acetate
extracts on TLC plates. The extracts from strains PAO1, PAO-
R1, PAO-JP2(pECP39), and PAO-JP2 were separated by TLC
and visualized under long-wave UV light. The extracts from
strains PAO1 and PAO-JP2 (pECP39) possessed a fluorescent
blue spot characteristic of PQS (Rf 5 0.6), whereas extracts from
strains PAO-R1 and PAO-JP2 produced no substance that was
similar to PQS (data not shown). These results were in agree-
ment with results from other PQS bioassays (8). The position of
PQS on the TLC plates was marked, and plates were then
exposed to x-ray film for 24 h. Multiple radiolabeled compounds
were evident on the autoradiograph (Fig. 2). It is interesting to
note here that very little (if any) radiolabeled anthranilate was
present in the extracts. Control experiments showed that ’73%
of anthranilate added to culture media will partition into the
organic phase of an ethyl acetate extract (data not shown).
Therefore, had there been unused radiolabeled anthranilate, one
would expect to find it in the ethyl acetate extracts of culture
supernatants, which was not the case. When comparing lane 5 of
Fig. 2, which contains only radiolabeled anthranilate, with lanes
1–4, it is apparent that the vast majority (or all) of the added
radiolabeled anthranilate was altered by the growing cells. More
importantly, when the autoradiograph and the TLC plate were
aligned, the PQS on the TLC plate corresponded exactly to a
radiolabeled compound on the autoradiograph (Rf 5 0.6) (see
arrowheads in Fig. 2). This radiolabeled compound was purified
and shown to be active in our PQS bioassay (8) (data not shown).
These results show that the radiolabeled anthranilate had been
converted into PQS. This finding led us to conclude that
anthranilate is a precursor of the intercellular signal, PQS. A
proposed synthesis pathway for PQS is presented in Fig. 3.
An Anthranilate Analog Represses PQS Production. The inhibition or
blocking of cell-to-cell signaling by bacteria is an obvious
target area for the development of drugs that will reduce
bacterial virulence. The identification of anthranilate as a
likely precursor of PQS provided us the opportunity to attempt
to interfere with PQS synthesis with the use of an anthranilate
analog. Previous studies in Escherichia coli have shown that
anthranilate analogs can inhibit anthranilate synthase activity
(17, 18). We therefore decided to examine the effect of methyl
anthranilate on PQS production by P. aeruginosa. P. aeruginosa
strain PAO1 was grown in the presence of increasing amounts
of methyl anthranilate, and culture supernatants were ex-
tracted with ethyl acetate and separated on TLC plates. PQS
was visualized under long-wave UV light and photographed to
quantify PQS densitometrically (see Materials and Methods).
Our results showed that the amount of PQS present in culture
supernatants decreased as the concentration of methyl anthra-
nilate increased (Fig. 4). It is also important to note here that
the growth of cultures was not affected by the presence of
methyl anthranilate at the concentrations used in these exper-
iments (data not shown). Taken together, these data indicated
that the production of PQS was inhibited by the anthranilate
analog methyl anthranilate.
Methyl Anthranilate Decreases P. aeruginosa Elastase Activity. PQS
has been shown to induce the lasB elastase gene in P. aeruginosa
Fig. 2. Autoradiograph of extracts from P. aeruginosa strains grown with
[14C]anthranilic acid. Extracts from 5-ml cultures of P. aeruginosa strains were
loaded onto the TLC plate as follows: lane 1, strain PAO1; lane 2, strain
PAO-R1; lane 3, strain PAO-JP2(pECP39); lane 4, strain PAO-JP2; lane 5, [14C]an-
thranilic acid (0.067 mCi). PQS is indicated by arrowheads. Strains were grown
for 19 h in the presence of 2 mCi of [14C]anthranilic acid. Cell-free supernatants
were extracted with ethyl acetate and separated by TLC as described in
Materials and Methods.
Fig. 3. Proposed synthesis scheme for PQS. In this synthetic pathway, an-
thranilate and b-ketodecanoic acid are condensed in a multistep reaction that
would produce PQS. A one-carbon unit must be released at some stage of the
reaction, which is indicated by CO2.
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(8). We hypothesized that a reduction in the amount of PQS
produced by P. aeruginosa, as shown in the experiments above,
would lead to a concomitant reduction in elastase production.
To determine whether this reduction in elastase production had
occurred, elastase activity from P. aeruginosa grown in the
presence of methyl anthranilate was determined. Cell-free su-
pernatants from cultures grown in the presence of increasing
concentrations of methyl anthranilate were assayed for elastase
activity as described in Materials and Methods. The results of this
experiment showed that increasing concentrations of methyl
anthranilate caused a concentration-dependent decrease in elas-
tase activity produced by P. aeruginosa strain PAO1 (Fig. 5). The
elastase activity produced by cells in the presence of 1.5 mM
methyl anthranilate was similar to the minimal amount produced
by P. aeruginosa strain PAO-JP3, a lasR, rhlR double mutant that
synthesizes no LasB elastase (14). These exciting results show
that a compound that is an analog of a precursor for a cell-to-cell
signal can inhibit the synthesis of the signal molecule and cause
a decrease in the expression of a virulence factor controlled
by the signal molecule. The implications of this finding are
discussed below.
Discussion
A common theme in secondary metabolite synthesis is the
condensation of primary metabolites to form compounds that
can then be enzymatically altered to obtain different activities.
We have determined that the primary metabolite anthranilate is
a precursor for the P. aeruginosa intercellular signal PQS. We
presented data that showed that radiolabeled anthranilate is
converted to PQS and have suggested a possible synthesis
pathway for PQS (Figs. 1–3). It is interesting to note that the
majority of radiolabeled anthranilate added to growing cultures
of P. aeruginosa strains that produce PQS was converted into
compounds that could be extracted by ethyl acetate (Fig. 1). This
finding suggests that exogenous anthranilate enters specific
pathways responsible for the production of extracellular second-
ary metabolites, which is surprising when one considers that
anthranilate is an intermediate in the tryptophan synthetic
pathway. Had the exogenous anthranilate been incorporated
into tryptophan, it would have been found in proteins, which are
usually not soluble in organic solvents such as ethyl acetate. In
cultures of quorum-sensing mutants that do not make PQS, the
radiolabeled anthranilate partitioned to the aqueous phase of
the organic extracts. These data suggest that exogenous anthra-
nilate is metabolized differently in quorum-sensing mutants that
do not make PQS.
Anthranilate has been proposed or shown to be a precursor for
numerous secondary metabolites in P. aeruginosa (10, 11), and
this finding is illustrated by the presence of several radioactive
compounds in culture supernatant extracts (Fig. 2). However, it
is interesting to point out that PQS appeared to be one of the
major end products (constituting ’12% of radioactivity in the
extract) for exogenous anthranilate (Fig. 2). Essar et al. (19)
speculated that some anthranilate synthases may be a part of
multienzyme complexes that cannot accept exogenous anthra-
nilate. If this hypothesis were true, exogenous anthranilate
would not be incorporated into all compounds synthesized from
anthranilate. The exogenous anthranilate would only enter into
certain synthetic pathways, which could explain why a large
portion of the radiolabeled anthranilate was found in a relatively
small number of compounds. Alternatively, the addition of
anthranilate could cause cells to up-regulate the production of
specific secondary metabolites that contain anthranilate. Nev-
ertheless, P. aeruginosa converted a large portion of radiolabeled
anthranilate into exported compounds that were extracted by
ethyl acetate, and one of these compounds was PQS.
One approach for the development of novel antibacterial
treatments is to first identify a viable target. Considering this
approach, bacterial cell-to-cell signals have been an enticing
point at which to aim. In E. coli, specific analogs of the Vibrio
fischeri N-3-oxohexanoyl homoserine lactone signal and the P.
aeruginosa 3-oxo-C12-HSL signal have been shown to compete
for binding to LuxR and LasR, respectively, thereby acting as
antagonists of LuxR or LasR activity (20, 21). It has also been
found that a marine macroalga produced furanones (which are
similar to acyl-homoserine lactone molecules) that can inhibit
Fig. 4. An anthranilate analog partially blocks PQS production. PQS produc-
tion was monitored in P. aeruginosa strain PAO1 grown in the presence of
methyl anthranilate. Extracts from cultures grown in the presence of increas-
ing amounts of methyl anthranilate were separated by TLC, and PQS was
quantified by computer densitometry. Data are the mean 6 sn21 from three
separate experiments and are reported as a percentage of PQS produced by
the wild-type P. aeruginosa strain PAO1 grown without methyl anthranilate.
Fig. 5. Methyl anthranilate inhibits elastase production by P. aeruginosa.
Elastase activities were determined for cell-free supernatants of P. aeruginosa
strains PAO1 (solid bars) and PAO-JP3 (striped bars) grown in the presence of
increasing amounts of methyl anthranilate. Activity is reported as a percent-
age of activity seen from the wild-type P. aeruginosa strain PAO1 grown
without methyl anthranilate. Data are the mean 1 sn21 from duplicate assays
performed during three separate experiments.
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acyl-homoserine lactone signaling by Serratia liquefaciens and
Vibrio fischeri (22). In addition, an antibacterial compound has
been shown to have an effect on the production of an intercel-
lular signal. Triclosan, a common antibacterial additive, inhibits
FabI, an acyl carrier protein reductase that is important for the
synthesis of C4-HSL and 3-oxo-C12-HSL by P. aeruginosa (23).
The studies presented here were started with the hope of
learning more about metabolic events that lead to the control of
virulence factor expression by intercellular signaling. Our long-
term goal is to learn how to exploit bacterial cell-to-cell com-
munication to develop treatments that will decrease bacterial
virulence. With this goal in mind, we viewed our determination
that anthranilate was a PQS precursor as an opportunity to alter
the production of an intercellular signal (PQS). In E. coli,
anthranilate is synthesized from chorismate through the enzy-
matic action of at least TrpE (see ref. 24 for a review). TrpE is
an anthranilate synthase that can act alone or in conjunction with
TrpG, which is a glutamine amidotransferase. TrpE contains a
tryptophan-binding site that is responsible for feedback inhibi-
tion of the tryptophan pathway in E. coli. Two separate anthra-
nilate synthase genes, trpE and phnA, have been identified and
characterized in P. aeruginosa (19, 25). The trpE gene was shown
to be part of the tryptophan synthetic pathway, and phnA was
important for pyocyanin production (19, 25). To interrupt
anthranilate metabolism in P. aeruginosa, we grew cells in the
presence of an anthranilate analog, methyl anthranilate. Our
results showed that this compound had a concentration-
dependent negative effect on the production of PQS (Fig. 4). We
presume that methyl anthranilate affects PQS production by
competing with anthranilate in the proposed reaction in which
anthranilate and b-ketodecanoic acid are condensed (see Fig. 3).
Alternatively, methyl anthranilate could be converted into a
compound that leads to feedback inhibition of an anthranilate
synthase (or other enzyme) that is necessary for PQS production.
Considering the results in Fig. 4, the obvious question that
arose was whether methyl anthranilate would have an effect on
a PQS-controlled virulence factor. PQS has been shown to
control lasB in P. aeruginosa (8), so we performed assays to
determine the effect of methyl anthranilate on P. aeruginosa
elastase activity. These studies showed that elastase activity from
P. aeruginosa decreased as cells were grown in the presence of
increasing concentrations of methyl anthranilate (Fig. 5). This
finding was an exciting result because it meant that an analog of
a precursor for a cell-to-cell signal could be used to inhibit the
expression of a virulence factor controlled by the signal. Such a
finding indicated that the PQS synthetic pathway may be a
worthwhile target for the development of drugs that reduce P.
aeruginosa virulence.
Intercellular signaling is required for P. aeruginosa virulence
in several models of infection (26–28). It has also been shown
that C4-HSL and 3-oxo-C12-HSL are produced in the lungs of
mice (29) and cystic fibrosis patients (30) infected with P.
aeruginosa. There is even evidence that indicates that an increase
in the ratio of C4-HSL to 3-oxo-C12-HSL occurs during biofilm
growth in vitro, and similar signal ratios were found in sputum
from cystic fibrosis patients infected with P. aeruginosa (30).
Those results add importance to a previous report that showed
PQS can induce rhlI (encodes the C4-HSL synthase) in P.
aeruginosa (9). Considering all of these findings in conjunction
with the data presented in this report, the inhibition of PQS
synthesis may help to hinder the chain of events that leads to the
establishment of a chronic P. aeruginosa infection. As we learn
more about the intercellular signaling systems of bacteria, it
becomes apparent that multiple avenues of attack based on these
systems can be pursued in the search for new and effective
therapies for bacterial infections.
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